Saham Orang Dalam | 156,426,909 shares |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
N/A
Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
N/A
Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan UNIVERSAL BIOSENSORS INC transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di UBI / UNIVERSAL BIOSENSORS INC. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di UBI / UNIVERSAL BIOSENSORS INC. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-11 | 3 | Mullin Peter George Mullin Family Superannuation Fund | UBI | Common Stock | I | 1,519,261 | ||||||||
2025-02-11 | 3 | Mullin Peter George Mullin Family Trust | UBI | Common Stock | I | 577,000 | ||||||||
2025-02-11 | 3 | Mullin Peter George | UBI | Common Stock | D | 444,424 | ||||||||
2024-05-28 | 2024-05-27 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 0.1100 | 275,000 | 30 | 1,561,217 | ||||
2024-05-28 | 2024-05-27 | 4 | McLean Graham A | UBI | Common Stock | I | 0.1100 | 275,000 | 30 | 1,080,116 | ||||
2024-05-28 | 2024-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.1100 | 1,421,293 | 156 | 87,509,318 | ||||
2024-05-03 | 2024-05-01 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0.1500 | 217,182 | 33 | 970,802 | ||||
2024-05-03 | 2024-05-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.1500 | 29,289,424 | 4,393 | 86,088,025 | ||||
2024-05-03 | 2024-05-01 | 4 | McLean Graham A | UBI | Common Stock | I | 0.1500 | 180,116 | 27 | 805,116 | ||||
2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart By superannuation fund | UBI | Common Stock | I | 0.1500 | 30,000 | 4 | 394,666 | ||||
2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart | UBI | Common Stock | D | 0.1500 | 23,055 | 3 | 103,055 | ||||
2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 0.1500 | 10,000 | 2 | 1,286,217 | ||||
2024-05-03 | 2024-05-01 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0.1500 | 99,077 | 15 | 442,873 | ||||
2024-05-03 | 2024-03-25 | 4 | Sharman John Stewart | UBI | Common Stock | D | -1,000,000 | 80,000 | ||||||
2024-05-03 | 2024-03-25 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 1,000,000 | 1,276,217 | ||||||
2024-03-26 | 2024-03-25 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.2000 | 1,000,000 | 200 | 56,798,601 | ||||
2024-03-25 | 2024-03-25 | 4 | Sharman John Stewart | UBI | Common Stock | D | 0.2000 | 1,364,666 | 273 | 1,444,666 | ||||
2023-12-11 | 2023-12-11 | 4 | McLean Graham A Stock acquired by Milray Enterprises Pty Ltd ATF Graham McLean Family Trust | UBI | Common Stock | I | 0.1987 | 75,000 | 15 | 625,000 | ||||
2023-09-13 | 2023-09-11 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0.2200 | 100,000 | 22 | 753,620 | ||||
2023-08-21 | 2023-06-30 | 4 | Hoey David L | UBI | Common Stock | D | 0.1679 | 95,983 | 16 | 662,397 | ||||
2023-03-15 | 2023-03-14 | 4 | McLean Graham A | UBI | Common Stock | I | 0.2500 | 150,000 | 38 | 550,000 | ||||
2023-01-03 | 2023-01-01 | 4 | Balak Salesh | UBI | Common Stock | D | 50,000 | 388,558 | ||||||
2023-01-03 | 2023-01-01 | 4 | Sharman John Stewart | UBI | Common Stock | D | 50,000 | 80,000 | ||||||
2022-12-13 | 2022-12-12 | 4 | McLean Graham A | UBI | Common Stock | I | 0.2300 | 200,000 | 46 | 400,000 | ||||
2022-11-16 | 2022-11-16 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0.2400 | 17,848 | 4 | 653,620 | ||||
2022-11-16 | 2022-11-15 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0.2400 | 82,152 | 20 | 635,772 | ||||
2022-11-16 | 2022-11-11 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0.2500 | 50,000 | 12 | 553,620 | ||||
2022-08-18 | 2022-08-17 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0.2800 | 200,000 | 56 | 503,620 | ||||
2022-06-21 | 2022-05-27 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0.7700 | 43,796 | 34 | 343,796 | ||||
2022-06-15 | 2022-06-09 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0.3800 | 25,000 | 10 | 303,620 | ||||
2022-06-01 | 2022-06-01 | 4 | McLean Graham A | UBI | Common Stock | I | 0.4600 | 96,613 | 44 | 200,000 | ||||
2022-06-01 | 2022-05-31 | 4 | McLean Graham A | UBI | Common Stock | I | 0.4600 | 3,387 | 2 | 103,387 | ||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $1.00) | I | 1,920,000 | 1,920,000 | ||||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $0.92) | I | 1,920,000 | 1,920,000 | ||||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $0.20) | I | 0.5700 | 1,000,000 | 570 | 1,000,000 | ||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.4350 | 1,280,000 | 557 | 55,798,601 | ||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.7700 | 25,893,617 | 19,938 | 54,518,601 | ||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0.7700 | 10,000 | 8 | 278,620 | ||||
2022-05-31 | 2022-05-24 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0.4800 | 48,620 | 23 | 268,620 | ||||
2022-05-31 | 2022-05-27 | 4 | Sharman John Stewart By wife | UBI | Stock Option (Right to Buy) | I | 0.20 | 0.5700 | -1,000,000 | -570 | 0 | |||
2022-05-27 | 2022-05-27 | 4 | Balak Salesh | UBI | Common Stock | D | 0.7700 | 2,000 | 2 | 338,558 | ||||
2022-05-13 | 2022-05-12 | 4 | McLean Graham A Stock acquired by Graham McLean Family Trust of which Graham McLean is a member | UBI | Common Stock | I | 0.5000 | 64,962 | 32 | 100,000 | ||||
2022-05-13 | 2022-05-11 | 4 | McLean Graham A Stock acquired by Graham McLean Family Trust of which Graham McLean is a member | UBI | Common Stock | I | 0.5000 | 35,038 | 18 | 35,038 | ||||
2022-02-28 | 2022-02-24 | 4 | Balak Salesh | UBI | Common Stock | D | 30,000 | 336,558 | ||||||
2022-02-28 | 2022-02-24 | 4 | Sharman John Stewart | UBI | Common Stock | D | 30,000 | 30,000 | ||||||
2021-11-05 | 2021-11-05 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.7490 | 329,613 | 247 | 28,624,984 | ||||
2021-11-05 | 2021-11-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.7490 | 152,638 | 114 | 28,295,371 | ||||
2021-11-05 | 2021-11-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.7300 | 896,506 | 654 | 28,142,733 | ||||
2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | -40,000 | 0 | |||||
2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Performance Rights | D | 250,000 | 250,000 | ||||||
2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Performance Rights | D | 500,000 | 500,000 | ||||||
2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Common Stock | D | 40,000 | 306,558 | ||||||
2021-09-14 | 2021-08-19 | 4 | Sharman John Stewart | UBI | Performance Rights | D | 1,250,000 | 1,250,000 | ||||||
2021-09-14 | 2021-08-19 | 4 | Sharman John Stewart | UBI | Performance Rights | D | 2,500,000 | 2,500,000 | ||||||
2021-09-14 | 2020-03-24 | 4 | Sharman John Stewart By wife | UBI | Stock Option (Right to Buy) | I | 0.20 | 1,000,000 | 1,000,000 | |||||
2021-09-14 | 2020-03-24 | 4 | Sharman John Stewart | UBI | Stock Option (Right to Buy) | D | 0.20 | -1,000,000 | 1,364,666 | |||||
2021-01-11 | 2021-01-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | -12,559,109 | 27,246,227 | ||||||
2020-12-23 | 2020-12-11 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | -40,000 | 0 | |||||
2020-12-23 | 2020-12-11 | 4 | Balak Salesh | UBI | Common Stock | D | 40,000 | 266,558 | ||||||
2020-11-03 | 2020-11-02 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0.3100 | 200,000 | 62 | 300,000 | ||||
2020-09-15 | 2020-09-15 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3400 | 784,687 | 267 | 39,805,336 | ||||
2020-09-15 | 2020-09-14 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3300 | 80,178 | 26 | 39,020,649 | ||||
2020-09-15 | 2020-09-10 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3250 | 135,135 | 44 | 38,940,471 | ||||
2020-09-09 | 2020-09-01 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.30 | 500,000 | 500,000 | |||||
2020-09-08 | 2020-09-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3250 | 322,315 | 105 | 38,805,336 | ||||
2020-09-08 | 2020-09-04 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3040 | 284,962 | 87 | 38,483,021 | ||||
2020-09-08 | 2020-09-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3210 | 100,000 | 32 | 38,198,059 | ||||
2020-07-30 | 2020-07-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.2500 | 730,999 | 183 | 12,559,109 | ||||
2020-07-30 | 2020-07-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.2500 | 1,461,998 | 365 | 38,098,059 | ||||
2020-07-09 | 2020-07-07 | 4 | CVC Ltd | UBI | Common Stock | D | 0.2200 | -23,820,765 | -5,241 | 0 | ||||
2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552,434 | ||||||||
2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552,434 | ||||||||
2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552,434 | ||||||||
2019-12-02 | 2019-12-02 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.2000 | 119,519 | 24 | 36,636,061 | ||||
2019-12-02 | 2019-11-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.2000 | 1,885,217 | 377 | 36,516,542 | ||||
2019-12-02 | 2019-11-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.1910 | 214,783 | 41 | 34,631,325 | ||||
2019-11-25 | 2019-11-12 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | -25,000 | 0 | |||||
2019-11-25 | 2019-11-12 | 4 | Balak Salesh | UBI | Common Stock | D | 25,000 | 226,558 | ||||||
2019-11-18 | 2019-11-15 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.1900 | 36,500 | 7 | 34,416,542 | ||||
2019-11-18 | 2019-11-13 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.1860 | 669,597 | 125 | 34,380,042 | ||||
2019-11-18 | 2019-11-01 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0.1800 | -3,439,866 | -619 | 18,442,469 | ||||
2019-09-12 | 2019-09-12 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0.1900 | 80,000 | 15 | 21,882,335 | ||||
2019-09-12 | 2019-09-11 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0.1900 | 1,710,683 | 325 | 21,802,335 | ||||
2019-09-12 | 2019-09-12 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.1900 | 80,000 | 15 | 33,710,445 | ||||
2019-09-12 | 2019-09-11 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.1900 | 1,710,683 | 325 | 33,630,445 | ||||
2019-07-09 | 2019-05-29 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | -73,334 | 0 | |||||
2019-07-09 | 2019-05-29 | 4 | Balak Salesh | UBI | Common Stock | D | 73,334 | 201,558 | ||||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0.00 | -105,000 | 0 | |||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0.00 | -25,000 | 0 | |||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0.00 | -40,000 | 0 | |||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0.00 | -40,000 | 0 | |||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 40,000 | 291,837 | ||||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 40,000 | 291,837 | ||||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 25,000 | 211,837 | ||||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 105,000 | 186,837 | ||||||
2019-03-06 | 2019-03-05 | 4 | CVC Ltd | UBI | Common Stock | D | 0.2100 | 176,151 | 37 | 23,820,765 | ||||
2019-03-05 | 2019-03-01 | 4 | CVC Ltd | UBI | Common Stock | D | 0.2100 | 100,000 | 21 | 23,644,614 | ||||
2019-01-14 | 2018-12-14 | 4 | Balak Salesh | UBI | Common Stock | D | 4,166 | 128,224 | ||||||
2019-01-14 | 2018-11-16 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | -25,000 | 0 | |||||
2019-01-14 | 2018-11-16 | 4 | Balak Salesh | UBI | Common Stock | D | 25,000 | 124,058 | ||||||
2019-01-14 | 2018-11-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0.00 | -25,000 | 0 | |||||
2019-01-14 | 2018-11-16 | 4 | Oates Adrian | UBI | Common Stock | D | 25,000 | 81,837 | ||||||
2019-01-14 | 2018-12-14 | 4 | Legleiter Rick L | UBI | Common Stock | D | 4,166 | 162,853 | ||||||
2018-12-06 | 2018-12-04 | 4 | CVC Ltd | UBI | Common Stock | D | 0.2100 | 1,500,000 | 315 | 23,544,614 | ||||
2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43,889,228 | ||||||||
2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43,889,228 | ||||||||
2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43,889,228 | ||||||||
2018-11-05 | 2018-10-11 | 4 | CVC Ltd | UBI | Common Stock | D | 0.2300 | 100,000 | 23 | 22,044,614 | ||||
2018-05-11 | 2018-05-09 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.2400 | 66,584 | 16 | 31,915,182 | ||||
2018-05-11 | 2018-05-09 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.2400 | 66,584 | 16 | 11,823,530 | ||||
2018-05-08 | 2018-05-04 | 4 | Legleiter Rick L | UBI | Common Stock | D | 0.2585 | 158,687 | 41 | 158,687 | ||||
2018-05-07 | 2018-05-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.2320 | 198,640 | 46 | 31,848,598 | ||||
2018-05-07 | 2018-05-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.2280 | 124,305 | 28 | 31,649,958 | ||||
2018-05-07 | 2018-05-07 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.2320 | 198,640 | 46 | 11,756,946 | ||||
2018-05-07 | 2018-05-03 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.2280 | 124,305 | 28 | 11,558,306 | ||||
2018-03-19 | 2018-03-15 | 4 | Hoey David L | UBI | Common Stock | D | 0.2051 | 100,000 | 21 | 566,414 | ||||
2018-02-05 | 2018-02-01 | 4 | Hoey David L | UBI | Common Stock | D | 0.2300 | 116,414 | 27 | 466,414 | ||||
2017-12-29 | 2017-12-29 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.3000 | 750,318 | 225 | 11,434,001 | ||||
2017-12-29 | 2017-12-28 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.2940 | 50,374 | 15 | 10,683,683 | ||||
2017-12-29 | 2017-12-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.2890 | 56,245 | 16 | 10,633,309 | ||||
2017-12-29 | 2017-12-22 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.2690 | 33,613 | 9 | 10,577,064 | ||||
2017-12-29 | 2017-12-29 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0.3000 | 2,250,953 | 675 | 20,091,652 | ||||
2017-12-29 | 2017-12-28 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0.2940 | 151,124 | 44 | 17,840,699 | ||||
2017-12-29 | 2017-12-27 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0.2890 | 168,737 | 49 | 17,689,575 | ||||
2017-12-29 | 2017-12-22 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0.2690 | 100,838 | 27 | 17,520,838 | ||||
2017-12-29 | 2017-12-29 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3000 | 3,001,271 | 900 | 31,525,653 | ||||
2017-12-29 | 2017-12-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.2940 | 201,498 | 59 | 28,524,382 | ||||
2017-12-29 | 2017-12-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.2890 | 224,982 | 65 | 28,322,884 | ||||
2017-12-29 | 2017-12-22 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.2690 | 134,451 | 36 | 28,097,902 | ||||
2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0.80 | 3,300,000 | 3,300,000 | |||||
2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0.60 | 2,700,000 | 2,700,000 | |||||
2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0.50 | 1,600,000 | 1,600,000 | |||||
2017-10-26 | 2017-10-24 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | -16,667 | 0 | |||||
2017-10-26 | 2017-10-24 | 4 | Balak Salesh | UBI | Common Stock | D | 16,667 | 99,058 | ||||||
2017-10-26 | 2017-10-24 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy | D | 0.00 | -25,000 | 0 | |||||
2017-10-26 | 2017-10-24 | 4 | Chambers Garry | UBI | Common Stock | D | 25,000 | 2,275,594 | ||||||
2017-10-26 | 2017-10-24 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0.00 | -25,000 | 0 | |||||
2017-10-26 | 2017-10-24 | 4 | Hodges Alastair | UBI | Common Stock | D | 25,000 | 2,871,615 | ||||||
2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0.00 | -16,667 | 0 | |||||
2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0.00 | -25,000 | 0 | |||||
2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Common Stock | D | 41,667 | 56,837 | ||||||
2017-03-27 | 2016-12-28 | 4 | Hodges Alastair | UBI | Restricted Shares of Common Stock | D | 3,030 | 2,846,615 | ||||||
2017-03-27 | 2016-12-28 | 4 | Oates Adrian | UBI | Restricted Shares of Common Stock | D | 3,030 | 15,170 | ||||||
2017-03-27 | 2016-12-28 | 4 | Chambers Garry | UBI | Restricted Shares of Common Stock | D | 3,030 | 2,250,594 | ||||||
2017-03-27 | 2016-12-28 | 4 | Balak Salesh | UBI | Restricted Shares of Common Stock | D | 3,030 | 82,391 | ||||||
2017-03-01 | 2017-03-01 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.3800 | 32,988 | 13 | 10,543,451 | ||||
2017-03-01 | 2017-02-28 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.3850 | 247,001 | 95 | 10,510,463 | ||||
2017-03-01 | 2017-02-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.3820 | 402,924 | 154 | 10,263,462 | ||||
2017-03-01 | 2017-03-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3800 | 32,988 | 13 | 27,963,451 | ||||
2017-03-01 | 2017-02-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3850 | 247,001 | 95 | 27,930,463 | ||||
2017-03-01 | 2017-02-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3820 | 402,924 | 154 | 27,683,462 | ||||
2017-02-17 | 2017-02-17 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0.3650 | 65,000 | 24 | 100,000 | ||||
2017-02-17 | 2017-02-14 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0.3350 | 35,000 | 12 | 35,000 | ||||
2017-02-16 | 2017-02-14 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.3400 | 7,782 | 3 | 9,860,538 | ||||
2017-02-16 | 2017-02-14 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3400 | 7,782 | 3 | 27,280,538 | ||||
2017-01-03 | 2016-12-29 | 4 | Hodges Alastair | UBI | Restricted Shares of Common Stock | D | 3,030 | 2,846,615 | ||||||
2017-01-03 | 2016-12-29 | 4 | Balak Salesh | UBI | Restricted Shares of Common Stock | D | 3,030 | 82,391 | ||||||
2017-01-03 | 2016-12-29 | 4 | Chambers Garry | UBI | Restricted Shares of Common Stock | D | 3,030 | 2,250,594 | ||||||
2017-01-03 | 2016-12-29 | 4 | Oates Adrian | UBI | Restricted Shares of Common Stock | D | 3,030 | 15,170 | ||||||
2016-12-08 | 2016-12-06 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3347 | 16,078 | 5 | 27,272,756 | ||||
2016-12-08 | 2016-12-06 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.3347 | 16,078 | 5 | 9,852,756 | ||||
2016-12-05 | 2016-12-05 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3282 | 112,009 | 37 | 27,256,678 | ||||
2016-12-05 | 2016-12-02 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3200 | 165,000 | 53 | 27,144,669 | ||||
2016-12-05 | 2016-12-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0.3196 | 1,807,004 | 578 | 26,979,669 | ||||
2016-12-05 | 2016-12-02 | 4 | VF Australian Equities Fund | UBI | Common Stock | D | 0.3200 | -154,736 | -50 | 0 | ||||
2016-12-05 | 2016-12-05 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.3282 | 112,009 | 37 | 9,836,678 | ||||
2016-12-05 | 2016-12-02 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.3200 | 154,736 | 50 | 9,724,669 | ||||
2016-12-05 | 2016-12-02 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.3200 | 165,000 | 53 | 9,569,933 | ||||
2016-12-05 | 2016-12-01 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0.3196 | 1,807,004 | 578 | 9,404,933 | ||||
2016-09-30 | 2016-09-28 | 4 | Hoey David L | UBI | Common Stock | D | 0.2900 | 150,000 | 44 | 350,000 | ||||
2016-07-20 | 3 | VF Australian Equities Fund | UBI | Common Stock | D | 309,472 | ||||||||
2016-07-20 | 3 | VF Australian Equities Fund | UBI | Common Stock | D | 309,472 | ||||||||
2016-07-20 | 3 | VF High Conviction Fund | UBI | Common Stock | D | 15,195,858 | ||||||||
2016-07-20 | 3 | VF High Conviction Fund | UBI | Common Stock | D | 15,195,858 | ||||||||
2016-07-20 | 3 | VF Strategic Equities Fund | UBI | Common Stock | D | 34,840,000 | ||||||||
2016-07-20 | 3 | VF Strategic Equities Fund | UBI | Common Stock | D | 34,840,000 | ||||||||
2016-07-11 | 3 | Coleman Craig E. By partnership | UBI | Common stock, par value US$0.0001 | I | 50,565,330 | ||||||||
2016-07-11 | 3 | Coleman Craig E. By partnership | UBI | Common stock, par value US$0.0001 | I | 50,565,330 | ||||||||
2016-07-11 | 3 | Coleman Craig E. By the Coleman Super Fund | UBI | Common stock, par value US$0.0001 | I | 25,612,665 | ||||||||
2016-07-11 | 3 | Coleman Craig E. By the Coleman Super Fund | UBI | Common stock, par value US$0.0001 | I | 25,612,665 | ||||||||
2016-06-14 | 2016-06-10 | 4 | Hoey David L | UBI | Common Stock | D | 0.2900 | 200,000 | 58 | 200,000 | ||||
2016-02-26 | 2016-02-17 | 4 | Balak Salesh | UBI | Common Stock | D | 2,500 | 79,361 | ||||||
2016-02-26 | 2016-02-17 | 4 | Oates Adrian | UBI | Common Stock | D | 2,500 | 12,140 | ||||||
2016-02-25 | 2016-02-17 | 4 | Hodges Alastair | UBI | Common stock | D | 2,500 | 2,843,585 | ||||||
2016-02-19 | 2016-02-17 | 4 | Chambers Garry | UBI | Common stock | D | 2,500 | 2,247,564 | ||||||
2016-02-19 | 2015-12-16 | 4 | Chambers Garry | UBI | Common stock | D | 0.4500 | -100,000 | -45 | 2,245,064 | ||||
2016-01-14 | 2015-12-31 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0.26 | -36,248 | 0 | |||||
2016-01-14 | 2015-12-31 | 4 | Hodges Alastair | UBI | Common Stock | D | 0.2600 | 36,248 | 9 | 2,841,085 | ||||
2016-01-14 | 2015-12-18 | 4 | Hodges Alastair | UBI | Common stock | D | 0.4600 | -30,000 | -14 | 2,804,837 | ||||
2015-07-13 | 2015-07-09 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0.00 | 60,000 | 60,000 | |||||
2015-07-13 | 2015-07-09 | 4 | Wright Paul | UBI | Common stock | D | 4,347 | 7,304 | ||||||
2015-03-02 | 2015-02-20 | 4/A | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 101,819.8200 | 337,428 | 34,356,858 | 337,428 | ||||
2015-03-02 | 2015-02-26 | 4 | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 99,812.5700 | 269,088 | 26,858,365 | 606,516 | ||||
2015-02-24 | 2015-02-20 | 4 | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 101,819.8200 | 337,428 | 34,356,858 | 337,428 | ||||
2015-02-03 | 2015-01-30 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0.00 | 40,000 | 40,000 | |||||
2015-02-03 | 2015-01-30 | 4 | Hodges Alastair | UBI | Common Stock | D | 4,347 | 2,834,837 | ||||||
2015-02-03 | 2015-01-30 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0.00 | 40,000 | 40,000 | |||||
2015-02-03 | 2015-01-30 | 4 | Chambers Garry | UBI | Common Stock | D | 4,347 | 2,345,064 | ||||||
2015-02-03 | 2015-01-30 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0.00 | 40,000 | 40,000 | |||||
2015-02-03 | 2015-01-30 | 4 | Oates Adrian | UBI | Common Stock | D | 4,347 | 9,640 | ||||||
2015-02-03 | 2015-01-30 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | 40,000 | 40,000 | |||||
2015-02-03 | 2015-01-30 | 4 | Balak Salesh | UBI | Common Stock | D | 4,347 | 76,861 | ||||||
2014-06-13 | 2014-06-12 | 4 | Wright Paul | UBI | Common stock | D | 2,040 | 2,957 | ||||||
2014-06-13 | 2013-12-12 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0.00 | 60,000 | 60,000 | |||||
2014-05-16 | 2014-05-15 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 7,670.0000 | 50,000 | 383,500 | 2,886,340 | ||||
2014-05-16 | 2014-05-14 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 8,940.0000 | 50,000 | 447,000 | 2,836,340 | ||||
2014-05-14 | 2014-05-14 | 4 | Hanley Denis | UBI | Common Stock | D | 8,127.9000 | 50,000 | 406,395 | 1,918,002 | ||||
2014-05-13 | 2014-05-13 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 11,500.0000 | 50,000 | 575,000 | 2,786,340 | ||||
2014-05-13 | 2014-05-12 | 4 | DENVER ANDREW By wife | UBI | Common Stock | I | 6,610.5000 | 30,000 | 198,315 | 90,797 | ||||
2014-05-08 | 2014-05-06 | 4 | Smith Christopher M | UBI | Common Stock | D | 11,249.9500 | 30,000 | 337,498 | 30,000 | ||||
2014-04-16 | 2014-04-14 | 4 | Wright Paul By Macquarie Super Manager | UBI | Common Stock | I | 56,567.0800 | 142,105 | 8,038,465 | 186,771 | ||||
2014-01-08 | 2013-12-12 | 4 | Davis Frederick Harry | UBI | Stock Option (Right to Buy) | D | 0.00 | 40,000 | 40,000 | |||||
2014-01-08 | 2013-12-12 | 4 | Davis Frederick Harry | UBI | Common Stock | D | 2,040 | 2,957 | ||||||
2014-01-06 | 2013-12-24 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0.22 | -384,224 | 0 | |||||
2014-01-06 | 2013-12-24 | 4 | Hodges Alastair | UBI | Common Stock | D | 0.2200 | 384,224 | 85 | 2,830,490 | ||||
2014-01-06 | 2013-12-12 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0.00 | 40,000 | 40,000 | |||||
2014-01-06 | 2013-12-12 | 4 | Hodges Alastair | UBI | Common Stock | D | 2,040 | 2,446,266 | ||||||
2014-01-06 | 2013-12-12 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | 40,000 | 40,000 | |||||
2014-01-06 | 2013-12-12 | 4 | Balak Salesh | UBI | Common Stock | D | 2,040 | 72,514 | ||||||
2014-01-06 | 2013-12-24 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0.22 | -288,168 | 0 | |||||
2014-01-06 | 2013-12-24 | 4 | Chambers Garry | UBI | Common Stock | D | 0.2200 | 288,168 | 63 | 2,340,717 | ||||
2014-01-06 | 2013-12-12 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0.00 | 40,000 | 40,000 | |||||
2014-01-06 | 2013-12-12 | 4 | Chambers Garry | UBI | Common Stock | D | 2,040 | 2,052,549 | ||||||
2014-01-06 | 2013-12-12 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0.00 | 40,000 | 40,000 | |||||
2014-01-06 | 2013-12-12 | 4 | Oates Adrian | UBI | Common Stock | D | 2,040 | 5,293 | ||||||
2013-10-09 | 2013-09-26 | 4 | Heinberg Marshall | UBI | Common Stock | D | 20,000 | 20,000 | ||||||
2013-10-04 | 2013-09-26 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Allison Denver | UBI | Common Stock | I | 200,000 | 2,736,340 | ||||||
2013-10-04 | 2013-09-26 | 4 | DENVER ANDREW | UBI | Common Stock | D | 28,000 | 437,050 | ||||||
2013-10-04 | 2013-09-26 | 4 | Hanley Denis Denis Hanley Superannuation Fund Pty Ltd | UBI | Common Stock | I | 200,000 | 954,105 | ||||||
2013-10-04 | 2013-09-26 | 4 | Hanley Denis Denis M Hanley Pty Ltd | UBI | Common Stock | I | 6,000 | 54,889 | ||||||
2013-10-04 | 2013-09-26 | 4 | Hanley Denis | UBI | Common Stock | D | 29,772 | 1,868,002 | ||||||
2013-06-11 | 2013-06-11 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0.22 | -384,224 | 384,224 | |||||
2013-06-11 | 2013-06-11 | 4 | Hodges Alastair | UBI | Common Stock | D | 84,529.2800 | 384,224 | 32,478,178 | 2,444,226 | ||||
2013-06-11 | 2013-06-11 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0.22 | -288,168 | 288,168 | |||||
2013-06-11 | 2013-06-11 | 4 | Chambers Garry | UBI | Common Stock | D | 63,396.9600 | 288,168 | 18,268,975 | 2,050,509 | ||||
2013-05-28 | 2013-05-27 | 4 | Wright Paul | UBI | Common Stock | D | 917 | 917 | ||||||
2013-05-28 | 2012-11-13 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0.00 | 37,500 | 37,500 | |||||
2013-02-20 | 2013-02-12 | 4 | Oates Adrian | UBI | Common Stock | D | 7,291.3800 | -8,333 | -60,759 | 3,253 | ||||
2013-01-08 | 2012-05-16 | 4 | DENVER ANDREW | UBI | Common Stock | I | 378,645.6800 | 676,153 | 256,022,412 | 2,536,340 | ||||
2013-01-08 | 2012-05-16 | 4 | DENVER ANDREW By spouse | UBI | Common Stock | I | 378,645.6800 | -676,153 | -256,022,412 | 60,797 | ||||
2013-01-08 | 2012-05-15 | 4 | DENVER ANDREW | UBI | Common Stock | I | 379,890.0000 | 678,375 | 257,707,879 | 1,860,187 | ||||
2013-01-08 | 2012-05-15 | 4 | DENVER ANDREW | UBI | Common Stock | D | 379,890.0000 | -678,375 | -257,707,879 | 409,050 | ||||
2012-12-28 | 2012-12-18 | 4 | Wilson Elizabeth | UBI | Common Stock | I | 3,999.6000 | 4,444 | 17,774 | 2,035,944 | ||||
2012-12-28 | 2012-12-19 | 4 | Balak Salesh | UBI | Common Stock | D | 1,999.8000 | 2,222 | 4,444 | 70,474 | ||||
2012-12-28 | 2012-12-18 | 4 | Wright Paul By Macquarie Super Manager | UBI | Common Stock | I | 14,999.4000 | 16,666 | 249,980 | 44,666 | ||||
2012-11-23 | 2012-11-13 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0.00 | 25,000 | 25,000 | |||||
2012-11-23 | 2012-11-13 | 4 | Hodges Alastair | UBI | Common Stock | D | 917 | 2,060,002 | ||||||
2012-11-23 | 2012-11-13 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0.00 | 25,000 | 25,000 | |||||
2012-11-23 | 2012-11-13 | 4 | Oates Adrian | UBI | Common Stock | D | 917 | 11,586 | ||||||
2012-11-23 | 2012-11-13 | 4 | Davis Frederick Harry | UBI | Stock Option (Right to Buy) | D | 0.00 | 25,000 | 25,000 | |||||
2012-11-23 | 2012-11-13 | 4 | Davis Frederick Harry | UBI | Common Stock | D | 917 | 917 | ||||||
2012-11-21 | 2012-11-13 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | 25,000 | 25,000 | |||||
2012-11-21 | 2012-11-13 | 4 | Balak Salesh | UBI | Common Stock | D | 917 | 68,252 | ||||||
2012-11-21 | 2012-11-13 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0.00 | 25,000 | 25,000 | |||||
2012-11-21 | 2012-11-13 | 4 | Chambers Garry | UBI | Common Stock | D | 917 | 1,762,341 | ||||||
2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | -8,333 | 0 | |||||
2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | -8,333 | 0 | |||||
2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0.00 | -21,666 | 73,334 | |||||
2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Common Stock | D | 38,332 | 67,335 | ||||||
2012-08-27 | 2012-08-23 | 4 | Davis Frederick Harry By wife | UBI | Common Stock | I | 0.7000 | 23,376 | 16 | 28,747 | ||||
2012-08-27 | 2012-08-22 | 4 | Davis Frederick Harry By wife | UBI | Common Stock | I | 0.7000 | 5,371 | 4 | 5,371 | ||||
2012-03-06 | 2012-02-27 | 4 | Hodges Alastair | UBI | Common Stock | D | 0.7300 | -1,000,000 | -730 | 2,059,085 | ||||
2012-01-24 | 2011-03-07 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4200 | -25,000 | -36 | 17,431,617 | ||||
2012-01-24 | 2011-03-04 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4200 | -24,000 | -34 | 17,456,617 | ||||
2012-01-24 | 2011-03-03 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4200 | -10,000 | -14 | 17,480,617 | ||||
2012-01-24 | 2011-03-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4200 | -34 | -0 | 17,490,617 | ||||
2012-01-24 | 2011-02-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4200 | -1,083 | -2 | 17,490,651 | ||||
2012-01-24 | 2011-02-25 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4200 | -2,590 | -4 | 17,491,734 | ||||
2012-01-24 | 2011-02-23 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5200 | -37,279 | -57 | 17,494,324 | ||||
2012-01-24 | 2011-02-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3600 | -5,000 | -7 | 17,531,603 | ||||
2012-01-24 | 2011-02-17 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3500 | -5,000 | -7 | 17,536,603 | ||||
2012-01-24 | 2011-02-16 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3600 | -5,000 | -7 | 17,541,603 | ||||
2012-01-24 | 2011-02-15 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3600 | -5,000 | -7 | 17,546,603 | ||||
2012-01-24 | 2011-02-11 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3800 | -22,463 | -31 | 17,551,603 | ||||
2012-01-24 | 2011-02-09 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3600 | -22 | -0 | 17,574,066 | ||||
2012-01-24 | 2011-02-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3700 | -10,000 | -14 | 17,574,088 | ||||
2012-01-24 | 2011-02-07 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3800 | -50,000 | -69 | 17,584,088 | ||||
2012-01-24 | 2011-02-02 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5300 | -50,000 | -76 | 17,589,088 | ||||
2012-01-24 | 2011-02-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5200 | -50,000 | -76 | 17,639,088 | ||||
2012-01-24 | 2011-01-31 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5000 | -50,000 | -75 | 17,689,088 | ||||
2012-01-24 | 2011-01-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5200 | -50,000 | -76 | 17,739,088 | ||||
2012-01-24 | 2011-01-27 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5100 | -17,869 | -27 | 17,789,088 | ||||
2012-01-24 | 2011-01-25 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5200 | -73 | -0 | 17,806,957 | ||||
2012-01-24 | 2011-01-24 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5100 | -50,000 | -76 | 17,807,030 | ||||
2012-01-24 | 2011-01-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5100 | -50,000 | -76 | 17,857,030 | ||||
2012-01-24 | 2011-01-20 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5100 | -50,000 | -76 | 17,907,030 | ||||
2012-01-24 | 2011-01-19 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5200 | -50,000 | -76 | 17,957,030 | ||||
2012-01-24 | 2011-01-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5100 | -50,000 | -76 | 18,007,030 | ||||
2012-01-24 | 2011-01-14 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4800 | -50,000 | -74 | 18,057,030 | ||||
2012-01-24 | 2011-01-13 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5000 | -50,000 | -75 | 18,107,038 | ||||
2012-01-24 | 2011-01-12 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4900 | -50,000 | -74 | 18,157,030 | ||||
2012-01-24 | 2011-09-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 0.9600 | -1,500,000 | -1,440 | 15,749,937 | ||||
2012-01-24 | 2011-08-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.1900 | -752 | -1 | 17,249,937 | ||||
2012-01-24 | 2011-07-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3000 | -341 | -0 | 17,250,689 | ||||
2012-01-24 | 2011-04-29 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5300 | -10,000 | -15 | 17,251,030 | ||||
2012-01-24 | 2011-04-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5200 | -10,000 | -15 | 17,261,030 | ||||
2012-01-24 | 2011-04-27 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.5100 | -10,000 | -15 | 17,271,030 | ||||
2012-01-24 | 2011-04-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4900 | -35,000 | -52 | 17,281,030 | ||||
2012-01-24 | 2011-04-20 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4400 | -10,000 | -14 | 17,316,030 | ||||
2012-01-24 | 2011-04-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4200 | -8,000 | -11 | 17,326,030 | ||||
2012-01-24 | 2011-04-15 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4200 | -7,500 | -11 | 17,334,030 | ||||
2012-01-24 | 2011-04-14 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4100 | -10,000 | -14 | 17,341,530 | ||||
2012-01-24 | 2011-03-30 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3900 | -155 | -0 | 17,351,530 | ||||
2012-01-24 | 2011-03-29 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3800 | -32 | -0 | 17,351,685 | ||||
2012-01-24 | 2011-03-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.3600 | -4,900 | -7 | 17,351,717 | ||||
2012-01-24 | 2011-03-10 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4000 | -25,000 | -35 | 17,356,617 | ||||
2012-01-24 | 2011-03-09 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4200 | -25,000 | -36 | 17,381,617 | ||||
2012-01-24 | 2011-03-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1.4100 | -25,000 | -35 | 17,406,617 |